Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
for
Triple Negative Breast Cancer, Breast Cancer,
Location: Dallas TX, Oklahoma City OK, Houston TX, Nashville TN,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT05377996
Phase 1, Phase 2, Recruiting
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight
Location: Dallas TX, Mesquite TX, Longview TX, Round Rock TX,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07752979
Phase 2, Recruiting
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Dallas TX, Little Rock AR, Cullman AL, Maplewood MN,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07823608
Phase 3, Recruiting
Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial
for
Radiation Protection
Location: Plano TX
Sponsor: Baylor Research Institute
Sex: All
Age: 0+
Code: NCT07467720
Recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Dallas TX, Norman OK, Oklahoma City OK, Tomball TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Hydrus® Microstent New Enrollment Post-Approval Study
for
Primary Open Angle Glaucoma
Location: Dallas TX, Austin TX, Overland Park KS, El Paso TX,
Sponsor: Alcon Research
Sex: All
Age: 45+
Code: NCT04553523
Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Southlake TX, Austin TX, The Woodlands TX, Katy TX,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase 2, Recruiting
Minima Stent System Post- Approval Study (PAS)
for
Pulmonary Artery Stenosis, Aortic Coarctation
Location: Dallas TX, Austin TX, Saint Louis MI, Aurora CO,
Sponsor: Renata Medical
Sex: All
Age: 0+
Code: NCT06828770
Recruiting
Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
for
Prosthetic-joint Infection
Location: Dallas TX, Oklahoma City OK, Shreveport LA, Katy TX,
Sponsor: Peptilogics
Sex: All
Age: 18 - 70+
Code: NCT07214311
Phase 2, Phase 3, Recruiting
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Kansas City KS, Memphis TN, St Louis MO,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07358078
Recruiting
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma,
Location: Dallas TX, San Antonio TX, Houston TX, Atlanta GA,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06600321
Phase 1, Recruiting
A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.
for
TP53 Y220C Mutation, Advanced Solid Tumors
Location: Dallas TX, San Antonio TX, Denver CO, Nashville TN,
Sponsor: PMV Pharmaceuticals, Inc
Sex: All
Age: 18+
Code: NCT07372625
Phase 1, Recruiting
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
for
Prostate Cancer,
Location: Dallas TX, St Louis MO, Nashville TN, Greenville SC,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18+
Code: NCT07545811
Phase 1, Recruiting
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Dallas TX, Austin TX, San Antonio TX, Houston TX,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase 3, Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
for
Advanced HR+/HER2- Breast Cancer
Location: Dallas TX, Kansas City KS, Toronto, New Haven CT
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
for
HIV-1-infection
Location: Fort Worth TX, Dallas TX, Bellaire TX, Kansas City MO,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT07708727
Phase 2, Phase 3, Recruiting
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)